Wang JW - Search Results

1

Extranodal natural-killer T-cell lymphoma: experience from China.

Wang L, Wang JW. Wang L, et al. Among authors: wang jw. Lancet Haematol. 2020 Jun;7(6):e441. doi: 10.1016/S2352-3026(20)30103-4. Lancet Haematol. 2020. PMID: 32470431 No abstract available.

2

[The clinical significance of serum Epstein-Barr virus-determined nuclear antigen 1 (EBNA1)/latent membrane protein 1 (LMP1) assay in patients with nasal type extranodal NK/T-cell lymphoma].

Yao N, Cui X, Wang J. Yao N, et al. Zhonghua Nei Ke Za Zhi. 2015 Feb;54(2):106-10. Zhonghua Nei Ke Za Zhi. 2015. PMID: 25907839 Chinese.

3

Autologous hematopoietic stem cell transplantation may improve long-term outcomes in patients with newly diagnosed extranodal natural killer/T-cell lymphoma, nasal type: a retrospective controlled study in a single center.

Wang J, Wei L, Ye J, Yang L, Li X, Cong J, Yao N, Cui X, Wu Y, Ding J, Zhang L. Wang J, et al. Int J Hematol. 2018 Jan;107(1):98-104. doi: 10.1007/s12185-017-2324-z. Epub 2017 Aug 30. Int J Hematol. 2018. PMID: 28856590

4

Prognostic significance of locally invaded sites and tissue types in patients with nasal extranodal natural-killer/T-cell lymphoma: a single-center retrospective analysis.

Dong GH, Li Y, Dong JY, Li X, Wan HF, Yang L, Wang JW, Gong LP, Zhao YH, Zhang H, Gao ZF, Liu HG. Dong GH, et al. Among authors: wang jw. Chin Med J (Engl). 2019 Jun 5;132(11):1305-1313. doi: 10.1097/CM9.0000000000000263. Chin Med J (Engl). 2019. PMID: 31009392 Free PMC article.

5

Long-term outcomes of patients treated with an EPOCHL regimen as first-line chemotherapy for newly diagnosed extranodal natural killer/T-cell lymphoma: a retrospective single-center study.

Wei L, Wang J, Ye J, Yang L, Cong J, Li X, Wu Y, Cui X, Ding J, Yao N, Yang J. Wei L, et al. Leuk Lymphoma. 2020 Feb;61(2):337-343. doi: 10.1080/10428194.2019.1663421. Epub 2019 Sep 13. Leuk Lymphoma. 2020. PMID: 31517553

6

The landscape of new drugs in extranodal NK/T-cell lymphoma.

Wang L, Li LR, Zhang L, Wang JW. Wang L, et al. Among authors: wang jw. Cancer Treat Rev. 2020 Sep;89:102065. doi: 10.1016/j.ctrv.2020.102065. Epub 2020 Jul 2. Cancer Treat Rev. 2020. PMID: 32653806 Review.

7

Treatment outcomes and prognostic analysis of elderly patients with extranodal natural killer/T-cell lymphoma, nasal type: a retrospective analysis.

Wei L, Cong J, Yang L, Ye J, Li X, Yao N, Yang J, Cui X, Wu Y, Ding J, Wang J. Wei L, et al. Leuk Lymphoma. 2020 Dec;61(12):2962-2968. doi: 10.1080/10428194.2020.1791848. Epub 2020 Jul 20. Leuk Lymphoma. 2020. PMID: 32686544

8

SVILE regimen, a combination of dexamethasone, vindesine, ifosfamide, pegaspargase, and etoposide, for treating relapsed/refractory extranodal natural killer/T-cell lymphoma, nasal type.

Wei L, Wang L, Cong J, Yang L, Ye J, Li X, Yao N, Yang J, Wang J. Wei L, et al. Leuk Res. 2020 Sep;96:106422. doi: 10.1016/j.leukres.2020.106422. Epub 2020 Jul 16. Leuk Res. 2020. PMID: 32721642

9

Outcomes of patients treated with SVILE vs. P-GemOx for extranodal natural killer/T-cell lymphoma, nasal type: a prospective, randomized controlled study.

Wei L, Yang L, Ye J, Cong J, Li X, Yao N, Yang J, Cui X, Ding J, Wu Y, Wang J. Wei L, et al. Cancer Biol Med. 2020 Aug 15;17(3):795-804. doi: 10.20892/j.issn.2095-3941.2020.0160. Cancer Biol Med. 2020. PMID: 32944407 Free PMC article. Clinical Trial.

10

PD-1 blockade in extranodal NK/T-cell lymphoma: who is in charge?

Wang L, Wang JW. Wang L, et al. Among authors: wang jw. Leukemia. 2020 Dec;34(12):3432-3433. doi: 10.1038/s41375-020-01046-8. Epub 2020 Oct 2. Leukemia. 2020. PMID: 33009482 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,068 results

Search Page

Filters